Reported Sunday, Spyre Shows Anti-α4β7, Anti-TL1A And Anti-IL-23 Antibodies Each Efficacious In Humanized Mouse Colitis Model, With Combinations Further Improving Efficacy, At UEGW 2026

Loading news article.

Reported Sunday, Spyre Shows Anti-α4β7, Anti-TL1A And Anti-IL-23 Antibodies Each Efficacious In Humanized Mouse Colitis Model, With Combinations Further Improving Efficacy, At UEGW 2026 | WAPE

Reported Sunday, Spyre Shows Anti-α4β7, Anti-TL1A And Anti-IL-23 Antibodies Each Efficacious In Humanized Mouse Colitis Model, With Combinations Further Improving Efficacy, At UEGW 2026

Article summary

Related companies

Comments —